Qualitative changes of ocular surface in the patients with dry eye syndrome after Systein Ultra systemic using

<p><strong>Purpose:</strong> To evaluate clinical efficiency of systemic usage of artificial tears drops Systein Ultra in the patients with different forms of dry eye syndrome.</p><p><strong>Methods:</strong> 42 patients (84 eyes) at the age of 21‑84 with di...

Full description

Bibliographic Details
Main Author: T. I. Poltanova
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2014-07-01
Series:Oftalʹmologiâ
Subjects:
Online Access:http://www.ophthalmojournal.com/index.php/opht/article/view/88
id doaj-5c4e32396ad94f3f85f76ba27de88b71
record_format Article
spelling doaj-5c4e32396ad94f3f85f76ba27de88b712020-11-25T00:48:37ZrusOphthalmology Publishing GroupOftalʹmologiâ 1816-50952014-07-01102697288Qualitative changes of ocular surface in the patients with dry eye syndrome after Systein Ultra systemic usingT. I. Poltanova0ГБОУ ВПО «Нижегородская государственная медицинская академия» Минздрава России<p><strong>Purpose:</strong> To evaluate clinical efficiency of systemic usage of artificial tears drops Systein Ultra in the patients with different forms of dry eye syndrome.</p><p><strong>Methods:</strong> 42 patients (84 eyes) at the age of 21‑84 with different pathogenic forms of ocular xerosis and degrees of it’s severity were investigated. Systein Ultra eye drops in instillations were prescribed to all patients 3 times a day. Complex examination of being investigated was performed before the drug administration, in 7 days and then in 2 weeks.</p><p><br /><strong>Results:</strong> Positive dynamics after the treatment was reavealed on average in 4‑7 days. There was decrease or absolute reduction of subjective and objective signs in the majority of cases. In the severest cases of the disease all investigated parameters were not changed.</p><p><br /><strong>Conclusion:</strong> The positive clinical result after artificial tears drops Systein Ultra using, accompanied by eye comfort without significant side effects, allows us to recommend Systein Ultra to the wide application in therapy of different pathogenic forms dry eye syndrome.</p>http://www.ophthalmojournal.com/index.php/opht/article/view/88dry eye syndrometear filmeye drops Systein Ultra
collection DOAJ
language Russian
format Article
sources DOAJ
author T. I. Poltanova
spellingShingle T. I. Poltanova
Qualitative changes of ocular surface in the patients with dry eye syndrome after Systein Ultra systemic using
Oftalʹmologiâ
dry eye syndrome
tear film
eye drops Systein Ultra
author_facet T. I. Poltanova
author_sort T. I. Poltanova
title Qualitative changes of ocular surface in the patients with dry eye syndrome after Systein Ultra systemic using
title_short Qualitative changes of ocular surface in the patients with dry eye syndrome after Systein Ultra systemic using
title_full Qualitative changes of ocular surface in the patients with dry eye syndrome after Systein Ultra systemic using
title_fullStr Qualitative changes of ocular surface in the patients with dry eye syndrome after Systein Ultra systemic using
title_full_unstemmed Qualitative changes of ocular surface in the patients with dry eye syndrome after Systein Ultra systemic using
title_sort qualitative changes of ocular surface in the patients with dry eye syndrome after systein ultra systemic using
publisher Ophthalmology Publishing Group
series Oftalʹmologiâ
issn 1816-5095
publishDate 2014-07-01
description <p><strong>Purpose:</strong> To evaluate clinical efficiency of systemic usage of artificial tears drops Systein Ultra in the patients with different forms of dry eye syndrome.</p><p><strong>Methods:</strong> 42 patients (84 eyes) at the age of 21‑84 with different pathogenic forms of ocular xerosis and degrees of it’s severity were investigated. Systein Ultra eye drops in instillations were prescribed to all patients 3 times a day. Complex examination of being investigated was performed before the drug administration, in 7 days and then in 2 weeks.</p><p><br /><strong>Results:</strong> Positive dynamics after the treatment was reavealed on average in 4‑7 days. There was decrease or absolute reduction of subjective and objective signs in the majority of cases. In the severest cases of the disease all investigated parameters were not changed.</p><p><br /><strong>Conclusion:</strong> The positive clinical result after artificial tears drops Systein Ultra using, accompanied by eye comfort without significant side effects, allows us to recommend Systein Ultra to the wide application in therapy of different pathogenic forms dry eye syndrome.</p>
topic dry eye syndrome
tear film
eye drops Systein Ultra
url http://www.ophthalmojournal.com/index.php/opht/article/view/88
work_keys_str_mv AT tipoltanova qualitativechangesofocularsurfaceinthepatientswithdryeyesyndromeaftersysteinultrasystemicusing
_version_ 1725255293030367232